The objective of the RATE-trial is to study if reduced anticoagulation targets during ECLS
diminish bleeding complications without an increase in thromboembolic complications or a
negative impact on outcome.
Phase:
Phase 3
Details
Lead Sponsor:
University Medical Center Groningen
Collaborators:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Erasmus Medical Center Isala Leiden University Medical Center OLVG Radboud University St. Antonius Hospital ZonMw: The Netherlands Organisation for Health Research and Development